Adagrasib (MRTX849) (C007B-021171)

InformationAdagrasib (MRTX849) Adagrasib (MRTX849) is a potent, selective, and covalent KRASG12C inhibitor that exhibits favorable drug-like properties, selectively modifies mutant cysteine 12 in GDP-bound KRASG12C and inhibits KRAS-dependent signaling.TargetsK-Ras(G12C)In vitroTo evaluate the breadth of MRTX849 activity, its effect on cell viability is determined across a panel of 17 KRASG12C-mutant and three non-KRASG12C-mutant cancer cell lines using 2D (3-day, adherent cells) and 3D (12-day, spheroids) cell growth conditions. MRTX849 potently inhibits cell growth in the vast majority of KRASG12C-mutant cell lines with IC50 values ranging between 10 nM and 973 nM in the 2D format and between 0.2 nM and 1042 nM in the 3D format..In vivoRapid tumor regression is observed at the earliest posttreatment tumor measurement and animals in the 30 mg/kg and 100 mg/kg cohorts exhibits evidence of a complete response at study Day 15. Dosing is stopped at study Day 16 and all 4 mice in the 100 mg/kg cohort and 2 out of 7 mice in the 30 mg/kg cohort remains tumor-free through study Day 70..Cell Research(from reference)Cell lines：MIA PaCa-2, H1373, H358, H2122, SW1573, H2030, KYSE-410 cells (G12C); H1299 (WT); A549 (G12S), HCT116 (G13D) cells Incubation Time：24 h. Specification: 0.98 Molecular Formula: C32H35ClFN7O2 Molecular Weight: 604.12 PubChem CID: 138611145 Isomeric SMILES: CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/A414244-SCI_82240ea47c09fe893fe2a458b889dae3.pdf

UPC:: 51202401
Condition:: New
Weight:: 0.97 Ounces
HazmatClass:: No;ManufacturerName=Aladdin Scientific"
WeightUOM:: LB
MPN:: A414244-50mg
CAS:: 2326521-71-3
Product Size:: 50mg
Hazard Statement Codes:: H302:H315:H319:H335
Precautionary Statement Codes:: P261:P280:P301+P312:P302+P352:P305+P351+P338
Controlled Substances and Cyanide:: Yes